Connect with us

Futures Jump On Relief From Tesla’s Blowout Earnings

Futures Jump On Relief From Tesla’s Blowout Earnings

US equity futures traded higher led by tech stocks, after Tesla’s results beat expectations…

Published

on

Futures Jump On Relief From Tesla's Blowout Earnings

US equity futures traded higher led by tech stocks, after Tesla’s results beat expectations boosting hopes for another strong earnings season and allayed fears of an imminent recession. The electric-vehicle maker’s shares jumped 7.2% in premarket trading on Thursday, while United Airlines rose 7% after forecasting it will return to profit this year. By contrast, Alcoa dropped 5.7% after reporting worse-than-expected sales and higher inventories due to supply-chain disruptions. S&P futures rose 0.85% or 37 points to 4,493 while Nasdaq 100 futs rose 1.2% to 14,175. A selloff in Treasuries resumed with a debate raging around whether inflation is peaking: the 10-year Treasury yield added 4 basis points. The euro and German bund yields rose after hawkish comments from European Central Bank officials. The dollar reversed losses, gold slumped to session lows and bitcoin jumped above $42,000.

Tesla’s earnings provided some relief for investors in tech after Netflix’s 35% slump on Wednesday raised concerns that the industry is being hit by inflation and expected rapid monetary-policy tightening by the Federal Reserve, according to Swissquote analyst Ipek Ozkardeskaya. "The macroeconomic conditions are not favorable for tech companies this year,” she said. “Although we haven’t seen a shocking migration from tech to value names, the tech companies that have shaky future earnings, and that can’t pass inflation on to their customers will likely suffer more."

Besides the surging Tesla, here are some other notable premarket movers:

  • Alcoa (AA US) shares decline 5.7% in premarket trading Thursday after the aluminum producer’s 1Q revenue missed estimates.
  • Netflix (NFLX US) shares fall 1.1% in premarket trading, extending Wednesday’s 35% plunge after the streaming firm announced a surprise decline in subscribers. Analysts highlight the company’s valuation and business model are under review, while inflation and competition are challenging for the stock.
  • United Airlines (UAL US) shares rise 7.5% in premarket trading after forecasting a profit this year. It has experienced a “rapid improvement” in both demand and revenue, according to MKM Partners.
  • U.S.-listed Macau casino operators Las Vegas Sands (LVS US), MGM Resorts (MGM US) and Melco Resorts (MLCO US) may be active after Shanghai reported a sharp increase in its number of seriously ill Covid patients.

Meanwhile, Chinese stocks extended this week’s rout as investors fretted over the economic effects of the nation’s Covid-Zero strategy, with lower-than-expected policy stimulus adding to their disappointment. An address by President Xi Jinping failed to soothe investors pining for more measures to support growth.

Bond bears have returned after Wednesday’s rally in Treasuries fueled by some investors including Bank of America and Nomura who said the panic over inflation and rate-hike bets had gone too far. However, a Federal Reserve anecdotal survey showed inflationary pressures remained strong. Meanwhile, equities stayed resilient to higher yields with their focus on earnings.

While the peak-inflation debate is intensifying, it’s unlikely to derail global central banks from their tightening path as commodity shortages from the war in Ukraine keep prices elevated. New Zealand inflation accelerated in the first quarter to the fastest pace in 32 years, validating the central bank’s pursuit of an aggressive tightening cycle. As noted yesterday, the U.S. 10-year real yield turned positive on Wednesday for the first time since March 2020 as traders added to bets on an aggressive Fed hiking cycle. However, the level failed to hold for long.

Separately, the Fed said in its Beige Book survey released Wednesday revealed that the U.S. economy grew at a moderate pace through mid-April, but rising prices and geopolitical developments created uncertainty and clouded the outlook for future growth.

“Strong demand allowed firms to pass through input cost increases in consumers,” Carol Kong, a strategist at Commonwealth Bank of Australia, said in a note. “The anecdotal evidence supports our view the FOMC is well behind the curve and needs to tighten policy aggressively.”

In Europe, the travel and construction sectors led gain, pushing the Stoxx Europe 600 Index 0.9% higher. CAC 40 outperforms, adding 1.2%, FTSE 100 lags, dropping 0.3%. Travel, construction and industrials are the strongest-performing sectors. French equities including Alstom and Saint-Gobain outperform after Wednesday’s sole debate between President Emmanuel Macron and nationalist leader Marine Le Pen reassured investors, with the pro-business incumbent seen as having dominated the encounter. Basic resources shares underperform in Europe, heading for the biggest three-day decline on a closing basis since January, as miners fall on 1Q production reports. ABB jumped 5.3% after the Swiss automation group reported better-than-expected earnings. Anglo American fell 8.2% in London after the mining company cut output goals and said costs would be higher than expected. Here are some of the biggest European movers today:

  • Nestle shares advance as much as 1.9% after the food company reported quarterly sales that exceeded market expectations. Analysts were impressed by the quality of the beat, highlighting the company’s pricing power.
  • ABB shares rise as much as 5.9% after the industrial automation and robotics group’s 1Q results topped expectations.
  • Akzo Nobel shares rise as much as 7.7% after the paint maker’s first-quarter adjusted operating income beat estimates, which Citi says is the result of pricing offsetting increased raw material costs for the first time this cycle.
  • Sartorius AG rises as much as 6.1%, biggest gainer on the Stoxx 600 Health Care subindex, after reporting earnings that included consensus beats on adjusted Ebitda and adjusted Ebitda margins.
  • Rexel rose as much as 7.3% after reporting 1Q revenue that topped estimates. The electrical-supplies company enjoyed pricing benefits, though there may be questions about why it didn’t raise guidance, Citi writes in a note.
  • Europeanlong-haul airlines rise on Thursday after U.S. peer United Air forecast a return to profit, with British Airways owner IAG +6.8%, Air France-KLM +4.1% and Lufthansa +3.9%.
  • Anglo American stock drop as much as 9.3% after the miner cut some output goals and raised costs guidance; Antofagasta also slumps following production decline, trades “ex-dividend.”
  • Carrefour falls as much as 4.4%, with Citi saying it could “pause” after a recent run even as it met 1Q sales expectations, with Latin America and French convenience stores outperforming.
  • Kinnevik shares slide as much as 9.2%, the most since February, after reporting its latest earnings, which included a drop in NAV to SEK243.50 from SEK424 y/y

Earlier in the session, Asian stocks edged lower, with Chinese and Hong Kong gauges leading losses on mounting growth concerns, while stocks in other parts of the region were mostly higher.  The MSCI Asia Pacific Index dropped as much as 0.5% Thursday before paring losses. Communication and consumer shares slipped as technology stocks got a boost for a second day from stabilizing bond yields. Japanese equities gained as the yen resumed weakening against the dollar. Chinese benchmarks extended declines as investors became increasingly worried about growth in the world’s second-largest economy. Chinese tech stocks fell for a third consecutive day, weighed by shares linked to electric-vehicle production as lockdowns on the mainland disrupt logistics. Investors have so far been disappointed at Chinese attempts to counter the economic impact of lockdowns. JD.com Inc. and Pinduoduo Inc. fell at least 1.4% each in New York premarket trading.

The CSI 300 Index capped a fifth day of losses, with lockdown-induced disruptions to supply chains and a series of disappointing monetary policy decisions quelling sentiment. “The timing of the policy stimulus would be key,” said Wai Ho Leong, a strategist at Modular Asset Management, referring to China’s monetary policy. He added that investors are also watching for stabilization of Covid-19 cases. The U.S. 10-year Treasury yield is down from a three-year high as some investors called for dip buying after the recent rout. Still, more monetary tightening is expected as the Federal Reserve said inflation pressures remain strong and that rising prices are clouding the economic outlook. More aggressive tightening by the Fed in early May, “such as a 75 basis-point hike or start of balance sheet reduction, may limit the People’s Bank of China’s options going forward,” said Marvin Chen, a strategist at Bloomberg Intelligence.

Japanese equities rose for a third day, driven by advances in electronics and machinery makers. Chemical makers also boosted the Topix, which gained 0.7%. Tokyo Electron and Fast Retailing were the largest contributors to a 1.2% rise in the Nikkei 225. The yen resumed weakening against the dollar after rallying 0.8% Wednesday.

India’s stock gauges rose for a second consecutive session to further reduce their sharp losses in the previous five days, driven by a continued recovery in index heavyweight technology and banking stocks. Reliance Industries surged to a record, giving the biggest boost to the indexes, after Morgan Stanley raised the price target on India’s most valuable company by 11%, citing the company’s focus on hydrogen production amid global energy transition. The S&P BSE Sensex rose 1.5% to 57,911.68 in Mumbai, while the NSE Nifty 50 Index advanced by an equal measure. There were 27 advancers, while 3 stocks declined. All but one the 19 sector sub-indexes compiled by BSE Ltd. climbed. Auto, consumer discretionary and finance companies were among the top performers

Australia's commodity-heavy stocks rose for a fifth day near a record high. The S&P/ASX 200 index rose 0.3% to close at 7,592.80, climbing for a fifth day, led by gains in the industrial and real estate sectors. The five-day advance brought the benchmark less than 1% shy of a record high hit in August. Brambles rose after boosting its underlying profit at constant FX rates forecast for the full year. Meanwhile, Megaport plunged the most on record following its third-quarter revenue update. Citi said the result was weaker than expected and saw misses on monthly recurring revenue (MRR) and Megaport Virtual Edge (MVE) additions. In New Zealand, the S&P/NZX 50 index fell 0.1% to 11,954.00

In FX, the Bloomberg dollar spot index rebounded back into the green after falling 0.1%. NZD and JPY are the weakest performers in G-10 FX. the Euro rallies while short-end German bond yields rise sharply in response to hawkish comments from ECB’s Wunsch and Guindos. EUR/USD rises 0.7% on to a 1.09 handle, outperforming in G-10. Money markets briefly price 75 bps of interest-rate hikes by the ECB’s December decision. China’s yuan dropped for a third day amid rising volatility; the currency extended declines amid rising volatility spurred by uncertainties surrounding policy support for the slowing economy. Cautious risk sentiment in global markets also weighed on the yuan ahead of Fed Chair Jerome Powell’s speech later on Thursday.

In rates, treasuries resumed their drop and are cheaper across the curve, following wider losses across bunds after hawkish comments from ECB’s Wunsch and Guindos as money markets priced in a more aggressive rate path for the euro-zone central bank. Treasury yields cheaper by ~5bp across the curve with 10-year around 2.87%; bunds lead losses in core rates. The German curve leads a broad-based bear-flattening move. Short end moves sharply lower, with 2y and 5y yields rising 10-12bps. USTs and gilts follow but outperform by ~3bps at the 10y point. Peripheral spreads are mixed, tightening to core at the short end, widening a touch at the back end. Futures activity during Asia session and European morning has featured continued selling of 10-year note contracts via 5k-lot block trades, most recent at 6:38am. The IG corporate issuance slate is not too busy and includes Development Bank of Japan 5Y SOFR and KfW 5Y SOFR; four deals priced $10.5b Wednesday, taking weekly volume above $40b. Focal points of U.S. session focus include appearance by Fed Chair Powell and 5-year TIPS auction, both at 1pm ET.

European bonds fell, with 10-year bund yields adding 5 basis points. Traders are betting on three quarter-point hikes from the ECB this year, after Governing Council member Pierre Wunsch said policy rates could be raised above zero before year-end, with the bank perhaps even deploying “restrictive” policy to get surging prices under control. Adding to the sense of urgency, fellow members Luis de Guindos and Martins Kazaks said a rate hike in July was possible.

In commodities, WTI drifts 1% higher to trade around $103; Brent is also firmer but off best levels and currently reside around the mid-point of USD 2.50/bbl ranges amid multiple pertinent updates. Namely, Russian-Ukraine negotiations and Mariupol developments, though we await Western confirmation, and China's COVID situation with strict curbs seemingly set to remain. Brazilian Oil Minister discussed raising oil output with the US amid the Ukraine crisis, while Brazil is willing to meet India's oil needs and wants Indian investment. Furthermore, the oil minister hopes oil prices stabilise below USD 100/bbl and said a high oil price is not good for producers and consumers, according to Reuters. Spot gold has continued to slip below the USD 1950/oz mark losing the 21-DMA at USD 1947 ahead of potential 50-DMA support at USD 1936.05/oz.

Bitcoin is firmer on the session but seemingly remains drawn to the USD 42k mark, in-spite of a brief foray above the figure.

Looking to the day ahead now, and central bank speakers include Fed Chair Powell and ECB President Lagarde, who are taking part in a panel on the global economy, as well as BoE Governor Bailey and the BoE’s Mann. Data releases from the US include the weekly initial jobless claims, and from the Euro Area there’s also the European Commission’s advance consumer confidence reading for April. Finally, earnings releases include Danaher, NextEra Energy, Philip Morris International, Union Pacific and Blackstone.

Market Snapshot

  • S&P 500 futures up 0.8% to 4,489.75
  • MXAP down 0.2% to 171.95
  • MXAPJ down 0.4% to 567.72
  • Nikkei up 1.2% to 27,553.06
  • Topix up 0.7% to 1,928.00
  • Hang Seng Index down 1.3% to 20,682.22
  • Shanghai Composite down 2.3% to 3,079.81
  • Sensex up 1.4% to 57,837.40
  • Australia S&P/ASX 200 up 0.3% to 7,592.79
  • Kospi up 0.4% to 2,728.21
  • STOXX Europe 600 up 0.4% to 461.91
  • Brent Futures up 0.9% to $107.76/bbl
  • German 10Y yield little changed at 0.93%
  • Euro up 0.6% to $1.0916
  • Gold spot down 0.6% to $1,945.26
  • U.S. Dollar Index down 0.39% to 100.00

Top Overnight News from Bloomberg

  • The ECB could lift policy rates above zero before the end of the year unless the euro-zone economy suffers a severe shock, and it might even have to deploy “restrictive” policy to get surging prices under control, Governing Council member Pierre Wunsch said
  • The ECB should be able to phase out asset purchases in July to pave the way for an interest-rate increase as early as that month, according to Vice President Luis de Guindos
  • The euro is being used less often as a global payment currency, posting its biggest percentage-point drop in more than a decade in March, as inflation and the war in Ukraine weigh on its appeal for transactions
  • Liquefied natural gas suppliers are asking clients to pay much higher rates for new long-term contracts, as a global effort to cut Russian imports is expected to keep the market tight for the next decade
  • President Xi Jinping defended China’s lockdown-dependent approach to fighting the pandemic, even as he sought to reassure the world that the country was still committed to opening its economy

A more detailed look at global markets courtesy of Newsquawk

 

Top Asian News

  • China State Energy Giants in Talks for Shell’s Russian Gas Stake
  • Japan Upgrades View of Economy Following Lifting of Covid Curbs
  • Bank of Korea Governor Rhee Warns of Debt, Aging Risks
  • BofA Said to Relocate Some Hong Kong Dealmakers to Singapore

European bourses are firmer across the board, Euro Stoxx 50 +1.2%, upside that occurred alongside renewed EUR upside; potentially, on a stronger currency alleviating some imported-inflation pain. However, the FTSE 100 -0.1% is the clear laggard in-spite of favourable GBP action with heavy-weight mining names pressured after Q1 production reports. Stateside, US futures are firmer across the board, NQ +1.0%, following a strong TSLA, +7% pre-market, report and ahead of commentary from Fed's Powell at two events.

Top European News

  • Fired BNP Boss Accused of ‘Emotional Terrorism’ Seeks $4 Million
  • Macron Brushes Off Attacks as Debate Reassures Investors
  • Dutch Government Votes to Tighten Bonus Rules For Finance Firms
  • Binance Limits Russia Services After EU Sanctions on Crypto

FX

  • Euro outperforms as dovish-leaning ECB member de Guindos tilts towards July hike and markets factor in 75 bps tightening before year end; EUR/USD hits 1.0936 high after breaching series of tech resistance levels and huge option expiries between 1.0900-05 (3.3 bln).
  • Dollar rattled by Euro exertions and DXY loses 100.000+ status in response.
  • Loonie and Kiwi diverge after mixed Canadian and NZ inflation data in relation to consensus, USD/CAD sub-1.2500 where 1.36bln expiry interest resides and NZD/USD sub-0.6800.
  • Yen back under pressure as yields rebound markedly and BoJ continues efforts to impose YCT, while keeping verbal currency intervention trained on the pace rather than scale of moves, USD/JPY above 128.00.
  • Pound undermined by EUR/GBP rally through technical resistance awaiting BoE rhetoric, while Yuan extends losses after latest weaker CNY fix and comments from Chinese media citing factors that may lead to further depreciation; Cable capped into 1.3100 and cross up over 21 and 50 DMAs to circa 0.8367.
  • Rouble rebounds as CBR says it is contemplating FX controls, USD/RUB just under 80.0000.

Fixed Income

  • Bonds reverse course after latest correction from bear market territory, with Bunds, Gilts and 10 year T-note trying to stay on 154.00, 118.00 and 119-00 handles.
  • Eurozone debt hit by hawkish sounding remarks from usual ECB dove de Guindos to the effect that data may determine a July hike.
  • French OATs hold up better than the rest after strong multi-tranche auction, on balance and Macron's outperformance during Presidential TV debate.

Commodities

  • WTI and Brent are firmer but off best levels and currently reside around the mid-point of USD 2.50/bbl ranges amid multiple pertinent updates.
  • Namely, Russian-Ukraine negotiations and Mariupol developments, though we await Western confirmation, and China's COVID situation with strict curbs seemingly set to remain.
  • Brazilian Oil Minister discussed raising oil output with the US amid the Ukraine crisis, while Brazil is willing to meet India's oil needs and wants Indian investment. Furthermore, the oil minister hopes oil prices stabilise below USD 100/bbl and said a high oil price is not good for producers and consumers, according to Reuters.
  • Peru is to declare a state of emergency to restore copper output at the Cuajone mine which was halted by protests in late February, according to Reuters.
  • Spot gold has continued to slip below the USD 1950/oz mark losing the 21-DMA at USD 1947 ahead of potential 50-DMA support at USD 1936.05/oz.

 

US Event Calendar

  • 08:30: April Continuing Claims, est. 1.46m, prior 1.48m
  • 08:30: April Initial Jobless Claims, est. 180,000, prior 185,000
  • 08:30: April Philadelphia Fed Business Outl, est. 21.4, prior 27.4
  • 10:00: March Leading Index, est. 0.2%, prior 0.3%

Central Bank Speakers

  • 13:00: Powell and Lagarde Take Part in IMF Panel on Global Economy

DB's Jim Reid concludes the overnight wrap

After a major selloff so far in April, sovereign bonds have pared back their losses over the last 24 hours as investors await comments today from Fed Chair Powell and ECB President Lagarde, who’ll be appearing together on an IMF panel on the global economy in the New York afternoon. The moves saw 10yr Treasury yields undergo a major intraday swing, falling more than -13bps from their intraday high of 2.98% during Asian trading, before closing at 2.83%, ahead of a +3bps move back higher this morning. There seemed to be a belief that if inflation was in the process of peaking out, the strength of the recent rates sell-off might be overdone.

But even as longer-dated yields moved lower on both sides of the Atlantic, the front end has been much more subdued by comparison, with the 2yr yield falling just -1.6bps yesterday and actually up +3bps this morning as investors continue to price in yet more Fed hikes over the near term. In fact, the amount of hikes priced in by December hit a fresh high of 227bps yesterday, and when you include the 25bp hike from last month, that implies the Fed will have tightened by more than 260bps for the year as a whole, so more than the 250bps worth of tightening we saw back in 1994. Market pricing is in line with what the Fed has been communicating of late. Even yesterday’s dovish leaning speakers, Presidents Daly and Evans, expressed a desire to get policy rates to neutral by the end of this year, which the most recent dot plot pegs at right around 250bps. Looking beyond this year as well, the rate that futures are pricing in for June 2023 hit a fresh closing high of 3.10%, although that’s still beneath our US economists’ call for a rate of 3.6% by then.

This growing drumbeat for monetary tightening was echoed in Europe too, where a couple of speakers signalled that an initial rate hike as early as July was potentially on the table. First, we heard from Latvian central bank governor Kazaks in a Bloomberg interview, who said that “A rate increase in July is possible”. And then Bundesbank President Nagel said that there could be a rate hike “at the beginning of the third quarter” if asset purchases were finished at the end of Q2. Currently, overnight index swaps are only fully pricing in a 25bp hike by the September meeting, and that’s when our own European economists are also expecting the ECB to move on rates as well. So if July were realised that would be a step up from where markets currently are right now. That said, this would fit the pattern we saw with the Fed, where markets progressively brought forward the expected timing of the first hike, having initially not expected one in 2022 at all to the point where one got priced in as early as March, even with the shock presented by Russia’s invasion of Ukraine.

Even with the increasing chatter around a July ECB hike, sovereign bonds in Europe pretty much echoed their US counterparts, with yields on 10yr bunds (-5.5bps), OATs (-4.6bps) and BTPs (-3.6bps) all moving lower. That came as European natural gas prices fell to another post-invasion low yesterday, down -1.21% at €92.63/MWh, though the war itself continues to show no sign of ending, with the commentary around any negotiations still taking on a very negative tone from both sides.

Equities put in a solid performance for the most part, although Netflix plunged -35.12% in trading after it reported a decline in subscribers in the first quarter, marking its worst daily performance since 2004. The move also leaves its share price at its lowest level in over 4 years, and the company’s YTD losses now stand at -62.45%, making it the worst performer in the entire S&P 500 on a YTD basis. My bingeing of Bridgerton 2 on holiday and starting the final series of Better Call Saul (the best show of the last few years) last night obviously hasn’t helped. Netflix’s decline dragged down a number of indices, with the FANG+ index of megacap tech stocks shedding -6.17%, primarily due to the Netflix move, whilst the NASDAQ fell -1.22%. The broader S&P 500 was more resilient, falling a mere -0.06%, with 378 stocks actually advancing showing that big cap tech was a drag. European shares were stronger, with the STOXX 600 gaining +0.84% as it more than recovered from the previous day’s losses.

Contrary to Netflix, Tesla revealed a record profit on strong demand for electric vehicles and through the sale of carbon credits in their earnings after the close. Going forward, they believe production will continue to grow despite supply chain issues beleaguering the industry. TSLA shares were +5.59% higher in after hours trading, moving back above $1,000 a share.

Most Asian equity markets are trading higher but with mainland China and Hong Kong stocks lagging, hurt by worries about the Chinese economy as the nation continues to battle Covid-19 outbreaks. The Shanghai Composite (-1.68%), CSI (-1.05%) and the Hang Seng (-1.56%) are trading in negative territory as a speech by the Chinese President Xi Jinping failed to bolster investor sentiment as markets have been disappointed with Chinese attempts at tackling the economic impact of lockdowns. Elsewhere, the Nikkei (+1.21%) and the Kospi (+0.48%) are trading up building on previous session gains. Looking ahead, stock futures are indicating a positive start after Tesla's earnings with the S&P 500 (+0.38%), Nasdaq (+0.55%) and DAX (+0.30%) in the green.

Oil prices are higher this morning with pressure in Europe to impose formal sanctions on Russian oil mounting. As I type, Brent futures are +1.04% higher at $107.91/bbl. In FX, the Japanese Yen continues to remain weaker and is -0.32% lower.

Elsewhere, we’re just 3 days away from the French presidential election runoff now. The second round candidates held their only debate last night, expounding their world views for about three hours. There didn’t seem to be anything from the debate that should tip the scales of the election in either direction. The polls continue to put President Macron ahead of Marine Le Pen, and yesterday’s releases maintained that pattern of Macron’s lead being outside the margin of error, with leads of 56.5-43.5 (Ipsos), 55.5-44.5 (Ifop), 55-45 (from Kantar), and 54-46 (from Harris).

There wasn’t a massive amount of data yesterday, but we did get a fresh reminder on inflationary pressures from the German PPI data, which came in at a year-on-year rate of +30.9% in March (vs. +30.0% expected). It’s also the fastest annual rate since the official series begins in 1949. Otherwise, there were US existing home sales for March, which fell to an annualised rate of 5.77m as expected, the lowest rate since June 2020.

Elsewhere the Credit Derivatives Determinations Committee said Russia’s remuneration of foreign currency bonds with rubles would constitute a default, triggering credit default swaps on Russian debt. Recall, US bank custodians were prevented from processing Russian dollar debt payments earlier this month. Russia still has some time to avoid a default, with a 30-day grace period to make creditors whole expiring on May 4.

To the day ahead now, and central bank speakers include Fed Chair Powell and ECB President Lagarde, who are taking part in a panel on the global economy, as well as BoE Governor Bailey and the BoE’s Mann. Data releases from the US include the weekly initial jobless claims, and from the Euro Area there’s also the European Commission’s advance consumer confidence reading for April. Finally, earnings releases include Danaher, NextEra Energy, Philip Morris International, Union Pacific and Blackstone.

Tyler Durden Thu, 04/21/2022 - 07:55

Read More

Continue Reading

International

Plan will put everyone in England within 15 minutes of green space – but what matters is justice not distance

The UK government wants every household in England to be within 15 minutes walk of a park, woodland or water.

Published

on

GIOIA PHOTO / shutterstock

How long does it take you to walk to your nearest park, woodland, lake or river? If it takes more than 15 minutes, according to the UK government’s new environmental improvement plan for England, something needs to be done about it. It says 38% people in England don’t have a green or blue space within a 15-minute walk of their home.

The plan promises a “new and ambitious commitment to work across government and beyond” to provide access to local green and blue spaces. It recognises the importance of connecting with nature, and that time spent outdoors is good for physical and mental health.

That’s a message researchers have been underlining for years, as a recent evidence review shows, and it has been amplified by COVID-19, which showed the importance of local green and blue spaces for wellbeing.

But the plan’s laudable ambitions overlook the ways our experiences of the outdoors are shaped by privileges of wealth and health.

If you live in a disadvantaged area, your local green space may be further away from your home, or you might have to share it with more people. As the campaign group Fields in Trust pointed out in a 2022 report, this is a question of justice.

However, there’s more to justice than the amount of space you have to share with others, or how long it takes you to get there. It’s also about how you feel and what you can do when you get there.

My own research highlights some key questions we need to ask if we’re to protect and improve our green spaces for future generations. Questions such as “Do I feel welcome here?” “Does this space meet my needs?” or “Do I get a say in how it is looked after?” highlight the fact that access is a matter of equality and democracy.

Some green spaces are greener than others

There are three key aspects of green and blue spaces that should be considered, and invested in, if the environmental improvement plan is to be more than wishful thinking.

People playing football
Some green spaces aren’t for everyone. 1000 Words / shutterstock

First, not all green and blue spaces are the same or provide the same benefits. The qualities of a football pitch are very different from those provided by a woodland walk along a stream.

Lumping them all together as “green and blue spaces” overlooks the need for a variety of spaces within easy reach to meet local people’s needs for physical and mental wellbeing.

Second, not all spaces are equally well looked after. Spaces that are fly-tipped or associated with antisocial activities can feel intimidating, especially after dark.

Green and blue spaces in disadvantaged areas need more care, and that requires time and money. As Public Health England noted, access to good quality green spaces is worse in more disadvantaged areas.

Third, simply being in a space won’t necessarily bring you all the benefits a space can offer. For people suffering from anxiety or depression, for example, more structured activities might be more helpful.

This could include time spent on rivers or allotments as part of the government’s pilot plan to tackle mental ill health by prescribing time in nature.

Be like Birmingham

In Birmingham, the local authority isn’t content with trumpeting the merits of its 600 parks. Instead, the city has developed a city of nature plan (I was part of a team that evaluated it).

At the heart of its approach is the idea of environmental justice, which it defines as “the fair treatment and meaningful involvement of all people regardless of race, colour, national origin, or income, with respect to the development, implementation and enforcement of environmental laws, regulations, and policies”.

Map of city highlighting parks
Birmingham’s 600 parks and open spaces are shared between 1.1 million residents of the city proper. Intrepix / shutterstock

To apply environmental justice to the city’s green spaces, Birmingham Council has assessed each of its 69 electoral ward in terms of access to green space of two hectares (about three football pitches) or more within 1,000 metres, as well as flood risk, urban heat island effects, health inequalities and deprivation.

Through this work, it has identified 13 of its 69 wards which are most in need of investment to reach a new “fair parks standard”. These mainly central areas have less accessible green space, are more at risk of flooding and urban heating, and are more deprived.

Starting with a pilot programme in Bordesley & Highgate Ward (setting for the BBC series Peaky Blinders), the plan is then to invest in a further five priority areas in central and east Birmingham: Balsall Heath West, Nechells, Gravelly Hill, Pype Hayes and Castle Vale.

This is the kind of approach that could guide investment in many other cities. It links funding with equalities and brings together climate change, public health and community issues. It shows that quality and equity can’t just be boiled down to the distance between your home and the nearest park.

The challenge now is to learn from Birmingham’s pioneering approach and apply similar principles elsewhere. At its best, this work can be used to highlight the challenges not only of applying resources equitably, but of ensuring the resources are there in the first place, an issue the environmental impact plan rather predictably glosses over.

Julian Dobson and colleagues were funded by the National Trust and National Lottery Heritage Fund to evaluate the Future Parks Accelerator programme. The views expressed here are the author's own.

Read More

Continue Reading

Spread & Containment

UN Initiative Targets And Doxxes Doctors And Nurses Who Don’t Follow COVID-19 Narrative

UN Initiative Targets And Doxxes Doctors And Nurses Who Don’t Follow COVID-19 Narrative

Authored by Katie Spence via The Epoch Times (emphasis…

Published

on

UN Initiative Targets And Doxxes Doctors And Nurses Who Don't Follow COVID-19 Narrative

Authored by Katie Spence via The Epoch Times (emphasis ours),

Nicole Sirotek is a registered nurse in Nevada with over a decade of experience working in some of the harshest conditions. When a hurricane devastated Puerto Rico, Sirotek and the organization she founded, American Frontline Nurses (AFLN), were there and gave out over 500 pounds of medical equipment and supplies.

National flags in front of the United Nations headquarters in Geneva, Switzerland. A group started as part of the United Nations Verified initiative has targeted nurses and doctors who don't follow the official narrative on COVID-19. (Fabrice Coffrini/AFP)

She hasn’t hesitated to be the first in when an emergency hits and medical professionals are needed. She’s lost count of the number of times she’s woken up on a cot in the middle of nowhere, boots still strapped to her feet, and ready to go.

But in tears during an interview with The Epoch Times, she detailed her ordeal with harassment and doxing over the past year and how she’s contemplated suicide due to crippling anxiety and depression.

It took such a toll on my mental health. I wasn’t sleeping and wasn’t eating,” Sirotek said.

To regain her mental health, she decided to step back from the group she started. But even that decision brought pain.

I said after I left New York, I’d do everything that I can to make sure it didn’t happen again,” Sirotek said, recalling the death she witnessed when she volunteered in New York as a nurse at the start of the COVID-19 pandemic. “I mean, for me to step back and take a break just makes me feel like I failed!”

A mobile station in New York on Dec. 29, 2021. (Richard Moore/The Epoch Times)

Sirotek is the victim of ongoing harassment. She’s received pictures of her children posed in slaughterhouses and hanging from a noose, drive-by photos of her house, and letters with white powder that exploded upon opening.

The Nevada State Board of Nursing was inundated with calls for Sirotek’s professional demise and flooded with anonymous complaints.

These complaints trace back to Team Halo, a social media influencer campaign formed as part of the United Nations Verified initiative and the Vaccine Confidence Project.

In response, Sirotek filed a police report. Her lawyer sent a cease-and-desist letter. The Epoch Times reviewed the documents.

The reply from the cease-and-desist letter? The client was acting within his First Amendment rights.

The Harassment Begins

In February 2022, Sirotek, as the face of AFLN, a patient advocacy network that boasts 22,000 nurses, appeared before Sen. Ron Johnson (R-Wis.) and testified about the harm patients were experiencing when they sought treatment for COVID-19.

She said she didn’t witness patients dying from the novel virus when she volunteered to work the front lines in New York at the start of the pandemic.

Instead, in her opinion, as a medical professional with multiple master’s degrees, patients were dying from “negligence” and “medical malfeasance.

Sirotek detailed the withholding by higher-ups of steroids and Ibuprofen and the prescribing of remdesivir. Additionally, there was zero willingness to consider possible early intervention treatments like ivermectin.

As the pandemic continued, such practices only escalated, Sirotek said.

Sirotek’s testimony resulted in cheers, widespread attention, and a target on her back.

Sen. Ron Johnson (R-WI) (C) speaks during a panel discussion titled COVID-19: A Second Opinion in Washington DC Jan. 24, 2022. (Drew Angerer/Getty Images)

[The harassment] all started the day we got back from DC,” Sirotek said.

At first, the attacks started with the typical “you’re transphobic, you’re anti-LGBTQ. I mean, they even called me racist,” Sirotek, who is Hispanic, recalled.

And as more patients sought AFLN’s help, the attacks increased in frequency and force.

At first, Sirotek said the attacks appeared to come from random people. But as the attacks continued, the terms “Project Halo,” “Team Halo,” and “#TeamHalo” continually cropped up. Especially on TikTok and from two accounts, “@jesss2019” and “@thatsassynp.”

“[@thatsassynp] just kept on saying how I was spreading misinformation, [that] ivermectin doesn’t work,” Sirotek said. “He kept targeting the Nevada State Board of Nursing because I was on the Practice Act Committee, and he did not feel like that was acceptable.”

Craig Perry, a lawyer representing nurses, including Sirotek, before the Nevada State Board of Nursing, confirmed Sirotek’s account. The executive director of the Nevada State Board of Nursing, Cathy Dinauer, declined to provide details on complaints or investigations, stating to The Epoch Times via email that they are “confidential.”

Sirotek said the complaints overwhelmed her ability to defend her nursing license.

“Untimely, they were filing so many complaints against me that [the Nevada State Board of Nursing] had to start filtering them as to what was applicable and not applicable. And [the complaints] just buried my nursing license to the point that we couldn’t even defend it,” Sirotek said.

Attacks Transition to Threats

Whenever Sirotek, or AFLN, tried to set up a community outreach webinar, hateful comments flooded their videos.

Julia McCabe, a registered nurse and the director of advocacy services for AFLN, told The Epoch Times that initially, they tried kicking the trolls out of the outreach videos. But they couldn’t keep up with the overwhelming numbers and had to shut the videos down, usually after only 10 minutes, she said.

To address the swarms, as McCabe labeled them, AFLN started charging an entrance fee for their webinars. But, McCabe said, they’d send out an email with a free access code to all of their subscribers before the webinar started. It helped, but not enough. The swarms kept coming. And the attacks escalated.

On June 5, 2022, @thatsassynp posted a video on TikTok calling for a “serious public uprising,” because the Nevada State Board of Nursing and other regulatory agencies weren’t disciplining nurses for spreading “disinformation.”

It became one of many such videos in the ensuing days. In the comments of one, he stated, “Also, stay tuned as [@jesss2019] will be addressing this as well. We are teaming up (as per usual) to raise awareness and demand action on this issue.” @jesss2019 responded, “Yes!!!! We will get this taken care of.”

Jess and Tyler Kuhk of @thatsassynp have “teamed up” on several occasions, targeting healthcare workers who question the COVID-19 narrative. Team Halo doesn’t officially list Kuhk on its site, but Kuhk posts with the #teamhalo.

In another video, he states, “If you’re new to this series, PLEASE watch the videos in my playlist ‘Nevada board of nursing.’ This started in Feb of this year.” His video has almost 35,000 “loves.”

On June 7, 2022, @jesss2019 posted a video on TikTok accusing Sirotek of spreading misinformation. It included a link to @thatsassynp, and his complaints about Sirotek to the Nevada State Board of Nursing and calls to remove her from the Practice Act Committee. She implored TikTok to boost the message. It, too, became one of many videos attacking Sirotek.

Specifically, @jesss2019 and @thatsassynp took issue with videos and posts from Sirotek, and AFLN, advocating for ivermectin and highlighting possible issues with remdesivir and the COVID-19 vaccines.

@jess2019 removed all of the above videos after The Epoch Times sought comment. The Epoch Times retains copies.

Sirotek says she received the first death threat against herself and her children around the same time, in June 2022.

“They cut off the pictures of my children’s faces from our family photos, where we take them every year on our front porch—we’ve got 11 years of those photos—and they cut them out and put them on the bodies of those little boys that have been sexually abused. And that’s what would get sent to my house. And I gave the police that,” Sirotek said.

In response to a request for comment from The Epoch Times, Sen. Johnson defended Sirotek.

“The COVID Cartel continues to frighten and silence those who tell the truth and challenge their failed response to COVID,” Johnson said. “It is simply wrong for Ms. Sirotek to be smeared and attacked like so many others who have had the courage and compassion to successfully treat COVID patients.”

As the threats continued and escalated, Sirotek also asked Perry to send a cease-and-desist letter to Tyler Kuhk on Aug. 1, 2022.

Kuhk, a nurse practitioner, is the person posting on TikTok under the pseudonym @thatsassynp.

The TikTok logo is pictured outside the company’s U.S. head office in Culver City, California, on Sept. 15, 2020. (Mike Blake/Reuters)

The letter sent to Kuhk alleges that on at least 10 different occasions, @thatsassynp encouraged a “public uprising” against Sirotek. It also details that his videos attacking Sirotek garnered over 400,000 views.

In response, McLetchie Law, a “boutique law firm serving prominent and emerging … media entities” responded to Perry by stating in a letter dated Aug. 16, 2022, “Both Nevada law and the First Amendment provide robust protections for our client’s (and others’) rights to criticize Ms. Sirotek’s dangerous views and practices—and to advocate for her removal from the Nursing Practice Advisory Committee of the Nevada State Board of Nursing.”

It also warned that any attempt to deter Kuhk from his chosen path would “backfire” and could result in a “negative financial impact.” Neither Kuhk nor McLetchie Law responded to The Epoch Times’ request for comment.

Unable to confirm the real name behind the TikTok account @jesss2019, and thus, unable to send her a legal letter, Sirotek posted some of the threats she’d received on Facebook, pleading for @jesss2019 to cease targeting her, and recognize the possible real-world harm.

In desperation, Sirotek asked Perry to file a legal name change, which he did on Sep. 15, 2022, hoping that would thwart people’s ability to look up Sirotek’s information. Perry told The Epoch Times, “Usually, when you do a name change, it’s a public record. But under extenuating circumstances, you can have that sealed.”

In Sirotek’s case, the court recognized the threat to her and her family’s safety, waived the publication requirement, granted the change, and sealed her record on Oct. 4, 2022.

Sirotek, at the behest of Perry, filed a police report detailing the harassment on Oct. 17, 2022.

In December 2022, @jesss2019 posted a video to TikTok doxing Sirotek by revealing her name change. The Epoch Times sought comment from @jesss2019 but has not received a response. After the request for comment, the user removed the video.

Team Halo and Social Media

On Dec. 17, 2020, Theo Bertram, a director at TikTok; Iain Bundred, the head of public policy at YouTube; and Rebecca Stimson, the UK head of public policy for Facebook, appeared before the UK’s House of Commons to explain what their social media sites were doing to combat “anti-vaccination disinformation.”

All three stated their companies employed a “two-pronged approach.” Specifically, “tackle disinformation and promote trusted content.”

Bundred stated that from the beginning of the year to November 2020, YouTube had removed 750,000 videos that promoted “Covid disinformation.”

The logos of Facebook, YouTube, TikTok, and Snapchat on mobile devices in a combination of 2017–2022 photos. (AP Photo)

Stimson stated that between March and October 2020, “12 million pieces of content were removed from [Facebook],” and it had labeled 167 million pieces with a warning.

Bertram stated that for the first six months of 2020, TikTok removed 1,500 accounts for “Covid violation” and had recently increased that activity. “In the last two months, we took action against 1,380 accounts, so you can see the level of action is increasing,” Bertram said.

“In October, we began work with Team Halo,” Bertram added. “I do not know if you are familiar with Team Halo. It is run by the Vaccine Confidence Project at the London School of Hygiene and Tropical Medicine and is about getting reliable, trusted scientists and doctors on to social media to spread trusted information.”

Team Halo’s Origins

On Sep. 20, 2022, Melissa Fleming, the under-secretary-general for global communications at the United Nations, appeared at the World Economic Forum to discuss how the United Nations was “Tackling Disinformation” regarding “health guidance” as well as the “safety and efficacy of the vaccine” for COVID-19.

A key strategy that we had was to deploy influencers,” Fleming stated. “Influencers who were really keen, who had huge followings, but really keen to help carry messages that were going to serve their communities.”

Fleming also explained that the United Nations knew its messaging wouldn’t resonate as well as influencers, so they developed Team Halo.

“We had another trusted messenger project, which was called Team Halo, where we trained scientists around the world, and some doctors, on TikTok. We had TikTok working with us,” Fleming said. “It was a layered deployment of ideas and tactics.”

Read more here...

Tyler Durden Wed, 02/01/2023 - 23:25

Read More

Continue Reading

Government

Why Is There A COVID Vaccine Mandate For Students?

Why Is There A COVID Vaccine Mandate For Students?

Authored by Margaret Anna Alice via ‘Through The Looking Glass’ Substack,

Letter to the…

Published

on

Why Is There A COVID Vaccine Mandate For Students?

Authored by Margaret Anna Alice via 'Through The Looking Glass' Substack,

Letter to the Stanford Daily: Why Is There a COVID Vaccine Mandate for Students?

“Not to know is bad. Not to wish to know is worse.”

—African proverb

I can’t figure out why Stanford is mandating the COVID vaccine for students.

  1. Is it to protect students from the virus, hospitalization, or death?

  2. Is it to protect them from other students?

  3. Is it to protect the Stanford community members from the students? 

If it’s to protect the students from catching COVID, that doesn’t make sense because the CDC says it “no longer differentiate[s] based on a person’s vaccination status because breakthrough infections occur.”

The CDC also acknowledges natural immunity, noting that “persons who have had COVID-19 but are not vaccinated have some degree of protection against severe illness from their previous infection.”

It appears Stanford didn’t get the memo because Maxwell Meyer—a double-jabbed, COVID-recovered alum who was nearly prohibited from graduating for choosing not to get boosted—was informed by an administrator that the booster mandate is “not predicated on history of infection or physical location.”

Despite living 2,000 miles away from campus and not being enrolled in coursework for his final term, Maxwell was told Stanford was “uniformly enforc[ing]” the mandate “regardless of student location.” Does that sound like a rational policy?

Fortunately, a different administrator intervened and granted Maxwell an exemption, but few Stanford students are so lucky. Almost everyone else simply follows the rules without realizing they’ve volunteered for vaccine roulette.

Cleveland Clinic study of the bivalent vaccines involving 51,011 participants found the risk of getting COVID-19 increased “with the number of vaccine doses previously received”—much to the authors’ surprise.

They were stumped as to why “those who chose not to follow the CDC’s recommendations on remaining updated with COVID-19 vaccination” had a lower risk of catching COVID than “those who received a larger number of prior vaccine doses.”

So if the vaccines don’t keep you from getting COVID, maybe they at least protect you from hospitalization?

That doesn’t wash, either, because according to data from the Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET)hospitalization rates for 18–64-year-olds have increased 11 percent since the vaccine rollout. Worse, kids under 18 have suffered a shocking 74 percent spike in hospitalizations.

An observational study conducted at Germany’s University Hospital Wuerzburg found:

“The rate of adverse reactions for the second booster dose was significantly higher among participants receiving the bivalent 84.6% (95% CI 70.3%–92.8%; 33/39) compared to the monovalent 51.4% (95% CI 35.9–66.6%; 19/37) vaccine (p=0.0028). Also, there was a trend towards an increased rate of inability to work and intake of PRN medication following bivalent vaccination.”

A new paper published in Science titled Class Switch Towards Non-Inflammatory, Spike-Specific IgG4 Antibodies after Repeated SARS-CoV-2 mRNA Vaccination even has Eric Topol concerned:

If you don’t know what that means, Dr. Syed Haider spells it out in this tweet. He explains that the shots “train your immune system to ignore the allergen by repeated exposure,” the end result being that “Your immune system is shifted to see the virus as a harmless allergen” and the “virus runs amok.”

Viral immunologist and computational virologist Dr. Jessica Rose breaks down the serious implications—including cancerfatal fibrosis, and organ destruction—of these findings.

Well, then does the vaccine at least prevent people from dying of COVID?

Nope. According to the Washington Post, “Vaccinated people now make up a majority of COVID deaths.”

At Senator Ron Johnson’s December 7, 2022, roundtable discussion on COVID-19 Vaccines, former number-one–ranked Wall Street insurance analyst Josh Stirling reported that, according to UK government data:

“The people in the UK who took the vaccine have a 26% higher mortality rate. The people who are under the age of 50 who took the vaccine now have a 49% higher mortality rate.”

Obtained by a Freedom of Information Act (FOIA) request to KBV (the association representing physicians who receive insurance in Germany), “the most important dataset of the pandemic” shows fatalities starting to spike in 2021.

Data analyst Tom Lausen assessed the ICD-10 disease codes in this dataset, and the findings are startling. His presentation includes the following chart documenting fatalities per quarter from 2016 to 2022:

This parallels the skyrocketing fatality rates seen in VAERS:

The vaccinated are more likely to contract, become hospitalized from, and die of COVID. If the vaccine fails on all of those counts, does it at least prevent its transmission to other students and community members?

The obvious answer is no since we already know it doesn’t prevent you from getting COVID, but this CDC study drives the point home, showing that during a COVID outbreak in Barnstable County, Massachusetts, “three quarters (346; 74%) of cases occurred in fully vaccinated persons.”

Maybe Stanford can tell us why they feel the mandate is necessary. Their booster requirement reads:

Why does Stanford have a student booster shot requirement? Our booster requirement is intended to support sustained immunity against COVID-19 and is consistent with the advice of county and federal public health leaders. Booster shots enhance immunity, providing additional protection to individuals and reducing the possibility of being hospitalized for COVID. In addition, booster shots prevent infection in many individuals, thereby slowing the spread of the virus. A heavily boosted campus community reduces the possibility of widespread disruptions that could impact the student experience, especially in terms of in-person classes and activities and congregate housing.”

The claim that “booster shots enhance immunity” links to a January 2022 New York Times article. It seems Stanford has failed to keep up with the science because the very source they cite as authoritative is now reporting, “The newer variants, called BQ.1 and BQ.1.1, are spreading quickly, and boosters seem to do little to prevent infections with these viruses.”

Speaking of not keeping up, that same article says the new bivalent boosters target “the original version of the coronavirus and the Omicron variants circulating earlier this year, BA.4 and BA.5.”

It then goes on to quote Head of Beth Israel Deaconess’s Center for Virology & Vaccine Research Dan Barouch, who says, “It’s not likely that any of the vaccines or boosters, no matter how many you get, will provide substantial and sustained protection against acquisition of infection.”

In other words, Stanford’s rationale for requiring the boosters is obsolete according to the authority they cite in their justification.

If Stanford is genuinely concerned about “reduc[ing] the possibility of widespread disruptions that could impact the student experience,” then it should not only stop mandating the vaccine but advise against it.

Some nations have suspended or recommended against COVID shots for younger populations due to the considerable risks of adverse events such as pulmonary embolism and myocarditis—from Denmark (under 50) to Norway (under 45) to Australia (under 50) to the United Kingdom (seasonal boosters for under 50).

The Danish Health Authority explains why people under 50 are “not to be re-vaccinated”:

“People aged under 50 are generally not at particularly higher risk of becoming severely ill from covid-19. In addition, younger people aged under 50 are well protected against becoming severely ill from covid-19, as a very large number of them have already been vaccinated and have previously been infected with covid-19, and there is consequently good immunity among this part of the population.”

Here’s what a Norwegian physician and health official had to say:

“Especially the youngest should consider potential side effects against the benefits of taking this dose.”
—Ingrid Bjerring, Chief Doctor at Lier Municipality

“We did not find sufficient evidence to recommend that this part of the population [younger age bracket] should take a new dose now.… Each vaccine comes with the risk for side effects. Is it then responsible to offer this, when we know that the individual health benefit of a booster likely is low?”
—Are Stuwitz Berg, Department Director at the Norwegian Institute of Public Health

new Nordic cohort study of 8.9 million participants supports these concerns, finding a nearly nine-fold increase in myocarditis among males aged 12–39 within 28 days of receiving the Moderna COVID-19 booster over those who stopped after two doses.

This mirrors my own findings that myocarditis rates are up 10 times among the vaccinated according to a public healthcare worker survey.

Coauthored by MIT professor and risk management expert Retsef Levi, the Nature article Increased Emergency Cardiovascular Events Among Under-40 Population in Israel During Vaccine Rollout and Third COVID-19 Wave reveals a 25 percent increase in cardiac emergency calls for 16–39-year-olds from January to May 2021 as compared with the previous two years.

The paper cites a study by Israel’s Ministry of Health that “assesses the risk of myocarditis after receiving the 2nd vaccine dose to be between 1 in 3000 to 1 in 6000 in men of age 16–24 and 1 in 120,000 in men under 30.”

Thai study published in Tropical Medicine and Infectious Disease found cardiovascular manifestations in 29.24 percent of the adolescent cohort—including myopericarditis and tachycardia.

Even Dr. Leana Wen, formerly an aggressive promoter of the COVID vaccine, admitted in a recent Washington Post op-ed:

“[W]e need to be upfront that nearly every intervention has some risk, and the coronavirus vaccine is no different. The most significant risk is myocarditis, an inflammation of the heart muscle, which is most common in young men. The CDC cites a rate of 39 myocarditis cases per 1 million second doses given in males 18 to 24. Some studies found a much higher rate; a large Canadian database reported that among men ages 18 to 29 who received the second dose of the Moderna vaccine, the rate of myocarditis was 22 for every 100,000 doses.”

All over the world, prominent physicians, scientists, politicians, and professors are asking pointed questions about illogical mandates; the safety and efficacy of the vaccines; and the dangers posed by the mRNA technology, spike protein, and lipid nanoparticles—including in the UKJapanAustraliaEurope, and the US.

Formerly pro-vaxx cardiologists such as Dr. Aseem MalhotraDr. Dean Patterson, and Dr. Ross Walker are all saying the COVID vaccines should be immediately stopped due to the significant increase in cardiac diseasesadverse events, and excess mortality observed since their rollout, noting that, “until proven otherwise, these vaccines are not safe.”

President of the International Society for Vascular Surgery Serif Sultan and Consultant Surgeon Ahmad Malik are also demanding that we #StopTheShotsNow.

And now, perhaps most notably, Dr. John Campbell has performed a 180-degree turn on his previous position and is saying it is time to pause the mass vaccination program “due to the risks associated with the vaccines”:

Rasmussen poll published on December 7, 2022, found 7 percent of vaccinated respondents have suffered major side effects—a percentage that echoes the 7.7 percent of V-Safe users who sought medical care as well as my own polling data.

Add the 34 percent who reported experiencing minor side effects, and you have nearly 72 million adults who’ve been hit with side effects from the vaccine.

Rasmussen Head Pollster Mark Mitchell explains:

“With 7% having a major side effect, that means over 12 million adults in the US have experienced a self-described major side effect that they attribute to the COVID-19 vaccine. That’s over 11 times the reported COVID death numbers. And also note that anyone who may have died from the vaccine obviously can’t tell us that in the poll.”

According to British Medical Journal Senior Editor Dr. Peter Doshi, Pfizer’s and Moderna’s own trial data found 1 in 800 vaccinated people experienced serious adverse events:

“The Pfizer and Moderna trials are both showing a clear signal of increased risk of serious adverse events among the vaccinated.…

“The trial data are indicating that we’re seeing about an elevated risk of these serious adverse events of around 1 in 800 people vaccinated.… That is much, much more common than what you see for other vaccines, where the reported rates are in the range of 1 or 2 per million vaccinees. In these trials, we’re seeing 1 in every 800. And this is a rate that in past years has had vaccines taken off the market.…

“We’re talking about randomized trials … which are widely considered the highest-quality evidence, and we’re talking about the trials that were submitted by Pfizer and Moderna that supported the regulators’ authorization.”

And this is the same Pfizer data the FDA tried to keep hidden from the public for 75 years.

Nothing to see here … except 1,223 deaths, 158,000 adverse events, and 1,291 side effects reported in the first 90 days according to the 5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports—and those numbers are likely underreported by a factor of at least 10 (my conservative calculations show an underreporting factor (URF) of 41 for VAERS).

Stanford is asking students to risk a 1 in 800 chance of serious adverse events—meaning the kind of events that can land you in the hospitaldisable you, and kill you. And for what?

Anyone who knows how to perform a cost-benefit analysis can see this is all cost and zero benefit.

Stanford’s own Dr. John Ioannidis—professor of medicine, epidemiology & population health, statistics, and biomedical data science—demonstrated that college students are at a near-zero risk of dying from COVID-19 in his “Age-Stratified Infection Fatality Rate of COVID-19 in the Non-Elderly Population.”

One of the six most-cited scientists in the world, Ioannidis found the median IFR was 0.0003 percent for those under 20 and 0.002 percent for twenty-somethings, concluding the fatalities “are lower than pre-pandemic years when only the younger age strata are considered” and that “the IFR in non-elderly individuals was much lower than previously thought.”

And yet Ioannidis’s employer is mandating an experimental product with extensively documented risks of severe harm.

What if a Stanford student dies and the coroner determines it was caused by the vaccine? That happened with George Watts Jr., a 24-year-old college student whose cause of death Chief Deputy Coroner Timothy Cahill Jr. attributed to “COVID-19 vaccine-related myocarditis.” Cahill says, “The vaccine caused the heart to go into failure.”

Notorious for mandating a booster not yet tested on humans (just like Stanford), Ontario’s Western University dropped its mandate on November 29, 2022, stating:

“We are revoking our vaccination policy and will no longer require students, employees, and visitors to be vaccinated to come to campus.”

That was the same day this article reported that 21-year-old Western University student and TikTok influencer Megha Thakur “suddenly and unexpectedly passed away” on November 24.

The timing is interesting, don’t you think? I’m sure it’s just a coincidence—even though this Clinical Research in Cardiology paper determined vaccine-induced myocardial inflammation was the cause of death in “five persons who have died unexpectedly within seven days following anti-SARS-CoV-2-vaccination.” In that analysis, the authors “establish the histological phenotype of lethal vaccination-associated myocarditis.”

Coincidences notwithstanding, Stanford may want to revoke the mandate before anything like that happens to one of its students … if it hasn’t already.

And if that’s not incentive enough, Stanford should consider the legal ramifications of mandating an experimental product. As this JAMA article warns:

“Mandating COVID-19 vaccines under an EUA is legally and ethically problematic. The act authorizing the FDA to issue EUAs requires the secretary of the Department of Health and Human Services (HHS) to specify whether individuals may refuse the vaccine and the consequences for refusal. Vaccine mandates are unjustified because an EUA requires less safety and efficacy data than full Biologics License Application (BLA) approval.”

Dr. Naomi Wolf delivered an impassioned speech to her alma mater, Yale, in which she called their booster mandate “a serious crime. It is deeply illegal. Certainly, it violates Title IX.” She explains:

“Title IX commits the university to not discriminate on the basis of sex or gender in getting an equal education.… I oversee a project in which 3,500 experts review the Pfizer documents released under court order by a lawsuit. In that document, there is catastrophic harm to women! And especially to young women! And especially to their reproductive health.… 72% of those with adverse events in the Pfizer documents are women!”

Other universities are currently facing lawsuits for mandating the COVID vaccine in violation of state laws, including one against Ohio University, University of Cincinnati, Bowling Green State University, and Miami University of Ohio.

Let’s recap.

Abundant evidence proves the vaccines FAIL to:

  • stop transmission

  • prevent contraction of COVID

  • lower hospitalization rates

  • reduce mortality

By the same token, this evidence shows the vaccines are ASSOCIATED with:

  • heightened transmission levels

  • greater chances of catching COVID

  • increased hospitalization rates

  • higher excess mortality

  • disproportionate injuries to women

Why is Stanford mandating these unsafe and ineffective products, again?

If logic, peer-reviewed studies, and legal concerns such as the violation of Title IX don’t convince Stanford to rescind the mandate, then what about its stated ethical commitment to upholding its Code of Conduct?

BMJ’s Journal of Medical Ethics recently published COVID-19 Vaccine Boosters for Young Adults: A Risk Benefit Assessment and Ethical Analysis of Mandate Policies at Universities. In this paper, eminent researchers from Harvard, Oxford, Johns Hopkins, and UC San Francisco (among other institutions) present five reasons university mandates are unethical.

They argue that the vaccines:

“(1) are not based on an updated (Omicron era) stratified risk-benefit assessment for this age group; (2) may result in a net harm to healthy young adults; (3) are not proportionate: expected harms are not outweighed by public health benefits given modest and transient effectiveness of vaccines against transmission; (4) violate the reciprocity principle because serious vaccine-related harms are not reliably compensated due to gaps in vaccine injury schemes; and (5) may result in wider social harms.” (emphases mine here and below)

They calculate that:

To prevent one COVID-19 hospitalisation over a 6-month period, we estimate that 31,207–42,836 young adults aged 18–29 years must receive a third mRNA vaccine.”

The authors conclude that:

“university COVID-19 vaccine mandates are likely to cause net expected harms to young healthy adults—for each hospitalisation averted we estimate approximately 18.5 SAEs and 1,430–4,626 disruptions of daily activities.… these severe infringements of individual liberty and human rights are ethically unjustifiable.”

This builds on a previously published BMJ Global Health article by some of the same authors titled, “The Unintended Consequences of COVID-19 Vaccine Policy: Why Mandates, Passports, and Restrictions May Cause More Harm Than Good.”

In this paper, the authors contend that COVID-19 vaccine mandates “have unintended harmful consequences and may not be ethical, scientifically justified, and effective” and “may prove to be both counterproductive and damaging to public health.”

Over the course of history, countless products once thought to be safe—from DDT to cigarettes to thalidomide for pregnant women to Vioxx—were eventually discovered to be dangerous and even lethal. Responsible governments, agencies, and companies pull those products from the market when the scientific data proves harm—and institutions that care about their community members certainly don’t mandate those products when evidence of risk becomes obvious, as is the case now for the experimental COVID vaccines.

Mahatma Gandhi once stated:

“An error does not become truth by reason of multiplied propagation, nor does truth become error because nobody sees it. Truth stands, even if there be no public support. It is self-sustained.”

The truth is clear to anyone who’s willing to look.

Will Stanford stop following the propaganda and start following the science—the real science and not the politicized science?

Will it stand up for the lives and health of its students—or will it wait until tragedy strikes another George Watts Jr. or Megha Thakur?

This is a historic opportunity for Stanford to prove its allegiance to people, scientific data, and critical thought over pharmaceutical donors, political pressures, and conformist thinking.

The stakes could not be higher.

*  *  *

For 16.4 cents/day (annual) or 19.7 cents/day (monthly), you can help Margaret fight tyranny while enjoying access to premium content like Memes by Themes“rolling” interviewspodcastsBehind the Scenes, and other bonus content:

Tyler Durden Wed, 02/01/2023 - 21:25

Read More

Continue Reading

Trending